The ESC today announced that Jeroen Bax, a Dutch cardiologist, will serve as the group’s President Elect for the next two years before becoming President starting in 2016. Bax is a professor of cardiology at Leiden University Medical Center. Bax is also known for his very close collaboration with Don Poldermans, the disgraced Dutch researcher…
Search Results for: poldermans
Newly Elected European Society Of Cardiology President Co-Authored Hundreds Of Papers With Don Poldermans
September 1, 2014 by Leave a Comment
First Retraction In the Don Poldermans Case
January 8, 2014 by Leave a Comment
Retraction Watch reports the first formal retraction of a paper by Don Poldermans, the disgraced Dutch cardiovascular researcher. Feringa HH, Elhendy A, Bax JJ, Boersma E, de Jonge R, Schouten O, Karagiannis SE, Schinkel AF, Lindemans J, Poldermans D. Coron Artery Dis. 2006 May;17(3):255-9. Baseline plasma N-terminal pro-B-type natriuretic peptide is associated with the extent of stress-induced…
Embers Of Poldermans Case Still Smoldering
March 24, 2013 by Leave a Comment
A prominent US cardiologist has rebuked Don Poldermans, the cardiovascular researcher at the center of a research scandal in the Netherlands. As reported here previously, Poldermans was fired for scientific misconduct by the Erasmus Medical Center in Rotterdam, where he had been a professor of medicine and the head of perioperative cardiac care. He was widely published and…
JACC Issues Notice of Concern Over Three Poldermans Papers
December 17, 2012 by 2 Comments
The editors of the Journal of the American College of Cardiology have issued a “Notice of Concern” over three JACC articles in which Don Poldermans, the disgraced Dutch researcher, served as the first or the last author. The editors relied on the report of the investigation committee at Erasmus Medical Center published in October. In each case the…
Don Poldermans And The Dutch Research Scandal
October 15, 2012 by 4 Comments
The publication last week of the final report from the Erasmus Medical Center on the Don Poldermans research scandal in the Netherlands ends the first and most explosive chapter of an ugly episode of scientific misconduct. But there are still many important questions regarding scientific integrity and the culture of medical research raised by the case. And…
Investigation in Poldermans Case Expands to Leiden University Medical Center
December 14, 2011 by 1 Comment
The investigation in the Dutch scientific misconduct case has now spread to the Leiden University Medical Center, according to media reports in the Netherlands. The case first came to public attention last month when the Erasmus Medical Center in Rotterdam fired prominent cardiovascular researcher Don Poldermans. (Click here for previous CardioBrief coverage of the case.) A spokesman for…
ESC May Re-Examine Guidelines in Wake of Poldermans Dismissal
November 23, 2011 by Leave a Comment
In the wake of the dismissal of Don Poldermans from the Erasmus Medical Center due to scientific misconduct (for background see this and this) the European Society of Cardiology has announced that Poldermans has resigned from his position as chairperson of the task force that created the ESC practice guidelines for preoperative cardiac risk assessment and…
Prominent Cardiologist And ESC Presidential Candidate Found Guilty Of Fraud
June 7, 2016 by 4 Comments
Updated– Karl-Heinz Kuck, a prominent German cardiologist and candidate for the presidency of the European Society of Cardiology, has been found guilty of fraud. He received a fine of 100,000 Euros and a prison sentence of one year. His prison sentence has been suspended as long as he does not commit additional fraud. According to multiple reports…
Study Raises New Questions About Perioperative Beta Blockers
October 5, 2015 by Leave a Comment
A large observational study finds that patients with hypertension who are taking beta blockers have higher rates of cardiovascular complications after noncardiac surgery. The study appears to support current guidelines against using beta blockers in the initial treatment of essential hypertension and may offer a contribution to the ongoing debate over the use of perioperative beta-blockade for noncardiac surgery…
The Shaky Scientific Edifice: Watching Retracted And Unretracted Papers
September 22, 2015 by Leave a Comment
The good news is that retracted papers really are worse than papers that have not been retracted. The bad news is that unretracted papers still have plenty of problems. That’s the inevitable conclusion of a fascinating new paper from Darrel Francis’s group in the UK. In the past few years the same group has exposed fraud and…
New England Journal Of Medicine Declines To Retract Papers From Disgraced Research Group
September 26, 2014 by 2 Comments
Like the Leaning Tower of Pisa, the two New England Journal of Medicine papers by disgraced Dutch researcher Don Poldermans will never stand straight. But like the famous Tower they are also unlikely to topple anytime soon. Without attracting a lot of attention, back in August the NEJM editors decided not to retract the papers or publish an expression…
Dutch Investigation Finds Serious Flaws In Influential New England Journal Of Medicine Study
July 30, 2014 by Leave a Comment
Erasmus Medical Center says it has wrapped up its investigation of Don Poldermans, the disgraced cardiology researcher who was fired for research misconduct. The full extent of the misconduct has never been known, and from an examination of the Erasmus report it appears likely that it never will be known. One major finding– though downplayed in…
Medicine Or Mass Murder? Guideline Based on Discredited Research May Have Caused 800,000 Deaths In Europe Over The Last 5 Years
January 15, 2014 by 2 Comments
Last summer British researchers provoked concern when they published a paper raising the possibility that by following an established guideline UK doctors may have caused as many as 10,000 deaths each year. Now they have gone a step further and published an estimate that the same guideline may have led to the deaths of as many…
European Heart Guidelines Based On Disgraced Research May Have Caused Thousands Of Deaths
July 31, 2013 by 2 Comments
Despite a 2-year-old scandal discrediting key evidence, current guidelines relying on this evidence have not been revised. As a result of physicians following these guidelines, some researchers say, it is possible that thousands of patients may have died each year in the UK alone. It is unlikely that a true understanding of the damage will…
2012 In Review: A Bad Year For Conventional Wisdom
December 24, 2012 by 3 Comments
This was a really grim year for anyone who thought we had things pretty well figured out. Time and again conventional wisdom was thrown out the window. 2012 forced the cardiology community to reconsider what it thought it knew about HDL cholesterol, platelet function tests, aspirin resistance, triple therapy, IABP, and more. One device company,…
Erasmus Medical Center Releases Final Report On Cardiovascular Research Scandal
October 9, 2012 by 2 Comments
After an extensive investigation, a large medical center in the Netherlands has confirmed earlier charges of research misconduct against a prominent cardiovascular researcher. On Tuesday, Erasmus MC in Rotterdam released a final report on the scientific integrity of trials conducted by Don Poldermans, a well-known and highly prolific Dutch cardiovascular researcher. The final report contains…
New Perspective on the Dutch Cardiovascular Research Scandal
April 17, 2012 by 2 Comments
New information and details have emerged about the cardiovascular research scandal in the Netherlands. One prominent cardiologist with close ties to the central character in the scandal has been cleared of wrongdoing by his institution and a feature magazine article sheds new light on that central character, Don Poldermans. As previously reported here last November,…
2011 in Review: Rivaroxaban, Sapien, Mark Midei, Conflicts of Interest, and Much More
December 31, 2011 by 4 Comments
Here’s a completely personal review of the past year in cardiology. Please write a comment if you strongly agree, disagree, or think something is missing. Drug of the Year: Rivaroxaban (Xarelto)– Despite a highly negative review from FDA reviewers, rivaroxaban gained FDA approval for the coveted stroke prevention in AF indication. The drug was approved…
More Details Emerge About the Dutch Research Scandal
November 20, 2011 by 5 Comments
More details have emerged about the research scandal in the Netherlands, in which prominent Erasmus Medical Center cardiovascular researcher Don Poldermans was fired for scientific misconduct. Anonymously leaked portions of a report from the Erasmus Medical Center investigation first appeared on Scribd over the weekend [Editor’s note: the Scribd link is no longer working]. Later an executive…
Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct
November 17, 2011 by 7 Comments
Updated– Don Poldermans, a well-known researcher in cardiovascular medicine in the Netherlands, has been fired for scientific misconduct by the Erasmus Medical Center in Rotterdam. According to a statement from Erasmus Medical center, an investigation found that Poldermans was careless in collecting the data for his research. In one study it was found that he used patient…
Recent Comments